Cannabis News Box

Cannabis Science buys patent for CBN compositions to treat sleep, anxiety and neurobehavioral disorders

Cannabis Science buys patent for CBN compositions to treat sleep, anxiety and neurobehavioral disorders

Bethan Rose Jenkins, Cannabis News Writer/Editorial

December 5, 2018


Filed under News, Research

Cannabis Science, Inc. (OTC: CBIS), a U.S. developer of cannabinoid-based medicines, has proudly confirmed receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and P...

cannabis science